Lymphocyte to monocyte ratio-based nomogram for predicting outcomes of hepatocellular carcinoma treated with sorafenib.

Yeonjung HaMohamed A Mohamed AliMolly M PetersenWilliam S HarmsenTerry M TherneauHan Chu LeeBaek-Yeol RyooSally BampohKenneth A VallesMohamad MadyVenkata R MissulaKritika PrasaiLewis R RobertsKang Mo Kim

Published in: Hepatology international (2020)

LMR measured before sorafenib administration predicts OS in advanced HCC patients. Our OS nomogram, incorporating LMR, can be offered to clinicians to improve their ability to assess prognosis, strengthen the prognosis-based decision-making, and inform patients in the clinic.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
decision making
prognostic factors
peritoneal dialysis
primary care
type diabetes
endothelial cells
patient reported outcomes
adipose tissue
immune response
dendritic cells
lymph node metastasis
insulin resistance